A thought leadership article published by Scrip, authored by Martin Lachs, Olivier Saulin and Chris Learn, on how CROs can best support increasing demand for Adoptive Cellular Transfer (ACT) clinical trials, and what sites can expect and commit to when participating in ACT trials.